Insider · CIK 0001308428

GALLAHUE KIERAN

Reports to the SEC for 7 companies · BREA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001308428

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-19	NVSTEnvista Holdings CorpA Award	Director	AAward	+9,330 sh	—	—	54,010
2026-05-08	EWEdwards Lifesciences CorpA Award	Director	AAward	+3,251 sh	—	—	3,251
2026-05-08	EWEdwards Lifesciences CorpA Award	Director	AAward	+1,064 sh	—	—	4,315
2025-06-10	NVSTEnvista Holdings CorpA Award	Director	AAward	+10.5K sh	—	—	44,680
2025-05-09	EWEdwards Lifesciences CorpA Award	Director	AAward	+1,154 sh	—	—	4,682
2025-05-09	EWEdwards Lifesciences CorpA Award	Director	AAward	+3,528 sh	—	—	3,528
2024-05-21	NVSTEnvista Holdings CorpA Award	Director	AAward	+10.1K sh	—	—	34,230
2024-05-08	EWEdwards Lifesciences CorpA Award	Director	AAward	+999 sh	—	—	4,054
2024-05-08	EWEdwards Lifesciences CorpA Award	Director	AAward	+3,055 sh	—	—	3,055
2024-02-23	EWEdwards Lifesciences CorpG Gift	Director	GGift	−7,056 sh	—	—	3,701
2024-02-23	EWEdwards Lifesciences CorpS Sale	Director	SSale	−3,058 sh	$87.61	−$268K	67,219
2024-02-23	EWEdwards Lifesciences Corp · Director Stock Option (Right to Acquire)M Exercise/Conversion	Director	MExercise/Conversion	−7,056 sh	—	—	0
2024-02-23	EWEdwards Lifesciences CorpM Exercise/Conversion	Director	MExercise/Conversion	+7,056 sh	$36.86	+$260K	10,757
2024-02-23	EWEdwards Lifesciences CorpG Gift	Director	GGift	+7,056 sh	—	—	70,277
2023-05-23	NVSTEnvista Holdings CorpA Award	Director	AAward	+5,425 sh	—	—	24,145
2023-05-12	EWEdwards Lifesciences CorpA Award	Director	AAward	+898 sh	—	—	3,701
2023-05-12	EWEdwards Lifesciences CorpA Award	Director	AAward	+2,803 sh	—	—	2,803
2022-05-24	NVSTEnvista Holdings CorpA Award	Director	AAward	+4,435 sh	—	—	18,720
2022-05-13	Intersect ENT, Inc.U Disposition from Tender	Director	UDisposition from Tender	−3,239 sh	$28.25	−$91.5K	5,011
2022-05-13	Intersect ENT, Inc.Stock Option (right to buy)U Disposition from Tender	Director	UDisposition from Tender	−12.5K sh	$28.25	−$353K	0
2022-05-13	Intersect ENT, Inc.Stock Options (Right to buy)U Disposition from Tender	Director	UDisposition from Tender	−6,035 sh	$28.25	−$170K	0
2022-05-13	Intersect ENT, Inc.Stock Options (Right to buy)U Disposition from Tender	Director	UDisposition from Tender	−3,473 sh	$28.25	−$98.1K	0
2022-05-13	Intersect ENT, Inc.Stock Option (right to buy)U Disposition from Tender	Director	UDisposition from Tender	−9,666 sh	$28.25	−$273K	0
2022-05-13	Intersect ENT, Inc.Stock Option (right to buy)U Disposition from Tender	Director	UDisposition from Tender	−5,734 sh	$28.25	−$162K	0
2022-05-13	Intersect ENT, Inc.Stock Options (Right to buy)U Disposition from Tender	Director	UDisposition from Tender	−25K sh	$28.25	−$706K	0
2022-05-13	Intersect ENT, Inc.Stock Options (Right to buy)U Disposition from Tender	Director	UDisposition from Tender	−13.2K sh	$28.25	−$374K	0
2022-05-13	Intersect ENT, Inc.Stock Option (right to buy)U Disposition from Tender	Director	UDisposition from Tender	−82.4K sh	$28.25	−$2.33M	0
2022-05-13	Intersect ENT, Inc.Stock Option (right to buy)U Disposition from Tender	Director	UDisposition from Tender	−3,390 sh	$28.25	−$95.8K	0
2022-05-13	Intersect ENT, Inc.Stock Option (right to buy)U Disposition from Tender	Director	UDisposition from Tender	−120K sh	$28.25	−$3.39M	0
2022-05-13	Intersect ENT, Inc.U Disposition from Tender	Director	UDisposition from Tender	−29.3K sh	$28.25	−$827K	0
2022-05-13	Intersect ENT, Inc.U Disposition from Tender	Director	UDisposition from Tender	−5,011 sh	$28.25	−$142K	0
2022-05-04	EWEdwards Lifesciences CorpA Award	Director	AAward	+737 sh	—	—	3,037
2022-05-04	EWEdwards Lifesciences CorpA Award	Director	AAward	+2,300 sh	—	—	2,300
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,202 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Director	JOther	−3,628 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Director	JOther	−1,116 sh	—	—	8,167
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Director	JOther	−8,167 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,583 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2022-02-08	EWEdwards Lifesciences Corp · Director Stock Option (Right to Acquire)M Exercise/Conversion	Director	MExercise/Conversion	−32.3K sh	—	—	0
2022-02-08	EWEdwards Lifesciences CorpS Sale	Director	SSale	−32.3K sh	$110.79	−$3.57M	3,433
2022-02-08	EWEdwards Lifesciences CorpM Exercise/Conversion	Director	MExercise/Conversion	+32.3K sh	$22.29	+$719K	35,689
2021-06-11	ARENA PHARMACEUTICALS INCA Award	Director	AAward	+3,067 sh	—	—	9,283
2021-06-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+7,202 sh	—	—	7,202
2021-06-03	Intersect ENT, Inc.A Award	Director	AAward	+3,239 sh	—	—	8,250
2021-06-03	Intersect ENT, Inc.Stock Option (right to buy)A Award	Director	AAward	+5,734 sh	—	—	5,734
2021-05-25	NVSTEnvista Holdings CorpA Award	Director	AAward	+4,020 sh	—	—	14,285
2021-05-07	EWEdwards Lifesciences CorpA Award	Director	AAward	+818 sh	—	—	3,433

Recent filings

Accepted (ET)
May 214
GALLAHUE KIERAN0001308428-26-000003
SEC(opens sec.gov)
May 84
GALLAHUE KIERAN0001225208-26-005050
SEC(opens sec.gov)
Jun 124
GALLAHUE KIERAN0001628280-25-031069
SEC(opens sec.gov)
May 94
GALLAHUE KIERAN0001225208-25-004951
SEC(opens sec.gov)
May 234
GALLAHUE KIERAN0001757073-24-000055
SEC(opens sec.gov)
May 94
GALLAHUE KIERAN0001225208-24-005893
SEC(opens sec.gov)
Feb 264
GALLAHUE KIERAN0001225208-24-002963
SEC(opens sec.gov)
May 254
GALLAHUE KIERAN0001757073-23-000047
SEC(opens sec.gov)
May 154
GALLAHUE KIERAN0001225208-23-005906
SEC(opens sec.gov)
May 314
GALLAHUE KIERAN0001757073-22-000075
SEC(opens sec.gov)
May 164
GALLAHUE KIERAN0001562180-22-004073
SEC(opens sec.gov)

Companies

Address

C/O ENVISTA HOLDINGS CORPORATION 200 S. KRAEMER BLVD., BLDG. E

BREA, CA, 92821